This information is intended for US healthcare professionals to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended for promotional purposes, nor to provide medical advice.

TREMFYA - Dosing Interval Adjustment During Every 8 Weeks Maintenance Therapy in Adult Patients with Active Psoriatic Arthritis

Last Updated: 01/04/2025

SUMMARY  

  • The company cannot recommend any practices, procedures, or usage that deviate from the approved labeling.
  • Please refer to the local labeling for information on the recommended dosing and administration of TREMFYA in adult patients with active psoriatic arthritis.

Literature Search

A literature search of MEDLINE®, EMBASE®, BIOSIS Previews®, DERWENT® (and/or other resources, including internal/external databases) conducted on 02 July 2024 did not identify any relevant citations pertaining to this topic.